Meds without Rx? Schedule H1 explained

Lexeo Therapeutics's LX2006 Has A Viable Regulatory Pathway And Timeline

Lexeo Therapeutics's LX2006 Has A Viable Regulatory Pathway And Timeline

These 2 Probiotic Strains Were Linked To Better Mood & Neuroplasticity

Supporting your mood may begin with your microbiome

DR MARC SIEGEL: A Senate candidate's medical title sparks a debate voters shouldn't ignore

Abdul El-Sayed supports Medicare for All but has never treated patients, raising questions about his claim to be a physician in the Senate race.

'800 seconds for a sick visit': Some factors driving antibiotic resistance have nothing to do with biology, says medical sociologist Julia Szymczak

'800 seconds for a sick visit': Some factors driving antibiotic resistance have nothing to do with biology, says medical sociologist Julia Szymczak

Cardiac specialists to strike next week over pay dispute

Cardiac surgeries are facing cancellations next week when perfusionists, who are members of the Fórsa trade union, engage in further strike action in a dispute over pay.

Antibiotics, oncology, and TB medications hit by supply disruptions

Antibiotics, oncology, and TB medications hit by supply disruptions

Form 144 MIRUM PHARMACEUTICALS For: 1 July

Form 144 MIRUM PHARMACEUTICALS For: 1 July

Why the secret to losing weight could be a simple tweak to your prescription. If you take medication every day, here's what you must ask your GP

Why the secret to losing weight could be a simple tweak to your prescription. If you take medication every day, here's what you must ask your GP

Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs

Medicare is launching a temporary bridge program that will cover select GLP-1 weight-loss medications from two of the pharmaceutical industry’s largest players. The program will extend coverage to Novo Nordisk’s (CPH: NOVO-B) Wegovy, both in injection and tablet form, marking a significant shift in how the federal health program approaches obesity treatment. Eli Lilly’s (NYSE: [] The post Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs appeared first on Foreign Policy Journal.

PMH halts elective surgery as broken AC stalls work

ONGOING works at Princess Margaret Hospital have forced the cancellation of all non-emergency elective surgeries, creating a “significant backlog” as technical problems stall renovations in the hospital’s main operating theatre, former Health Minister Dr Duane Sands has warned.

Role Of Digital Health, AI And Remote Monitoring In Obesity Care Delivery

Given the chronic and relapsing nature of the disease, long-term management often requires follow-up and individualized support beyond the initial treatment plan.

Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market?

So far, Pfizer has been an also-ran in the GLP-1 race, but that could change if its long-acting weight-loss medication takes off.

What to know about the temporary Medicare GLP-1 Bridge program

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half through the end of 2027. But with less than two weeks before its launch, questions remain over how it will operate. The Medicare GLP-1 Bridge, described by the Centers for Medicare and Medicaid Services (CMS)...

The F Ward trailer

The F Ward follows a group of medical interns sent to the underfunded Pines Hospital in Sydney for one final chance to complete their medical training. The F Ward premieres July 17 only on Stan.

On the left, actual doctors saying that losing weight isn't just about counting calories. On the right, people angrily pointing pointing at the Second Law of Thermodynamics. And... go [Interesting]

[link] [6 comments]

How Bioefficient Medical Diagnostics Is Improving Patient Care

Recently, one of our patients who is now a good friend shared her experience. In her words, “I have been putting off the appointment for months. Not because I was afraid of needles, but because I dreaded the process: the long queue, the paper forms, the four-day wait, and then a phone call that told [] The post How Bioefficient Medical Diagnostics Is Improving Patient Care appeared first on Vanguard News.

Friday Things #585

Friday Things 585 1. Next week, Dominic and I will head to New York for his quarterly scans, as well as neuroblastoma vaccine 9, and multiple other appointments. Please pray and send good thoughts his way for continued clear scans and remission, as well as limited side effects from the injection, and safe travels. 2. The kids started [] READ: Friday Things 585

RHR: The GLP-1 Blind Spot: What Ozempic Won’t Do for Your Metabolic Health

In this episode of Revolution Health Radio, Chris explores the science behind GLP-1 medications, including their powerful effects on appetite, weight loss, and cardiometabolic risk. He also uncovers the critical blind spots in the current conversation, including new research on long-term side effects, nutrient deficiencies, muscle loss, and the high rate of weight regain after discontinuation. You’ll learn why these drugs may be effective in the short term but fall short of addressing the root causes of obesity and metabolic dysfunction. Chris also explains who may benefit most from GLP-1 therapy and how to use these medications as part of a comprehensive strategy that includes nutrition, resistance training, and lifestyle interventions. The post RHR: The GLP-1 Blind Spot: What Ozempic Won’t Do for Your Metabolic Health appeared first on Chris Kresser.

25 things doctors wish more patients knew

From medication myths to overlooked symptoms, here are the insights physicians most want patients to carry into every appointment

Medicare Begins Covering Weight-Loss Drugs for Seniors, Ending a $50-a-Month Barrier

Medicare launched its GLP-1 Bridge program Tuesday, covering Wegovy and Zepbound for 10 million eligible seniors at 50 a month. It is the first time Medicare has covered a weight-loss drug specifically for obesity, not just diabetes: here is who qualifies and what doctors are warning.

Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know

If your doctor prescribes a GLP-1 medication for weight loss but your insurance won’t cover it, you have options.

AI Was Supposed to Save Your Doctor Time. A New Study Finds It’s Doing the Opposite

New research from Dartmouth reveals that fixing AI’s medical mistakes and missing follow-ups is actually draining physicians’ time. A new training method could fix it.

A New FDA-Approved Oral Weight Loss Pill Requires No Fasting: What Makes Foundayo Different from Other GLP-1 Drugs

FDA approved Foundayo (orforglipron) on April 1, 2026 — the only oral GLP-1 pill for weight loss you can take any time of day without fasting. Average weight loss: 12.4. Here's the breakdown.

Comprehensive guide on weight loss using GLP-1 medications: Here’s a detailed list!

Glucagon-like peptide-1 (GLP-1) therapies have offered clinically proven weight-loss and metabolic benefits. We know that obesity is a relapsing and chronic ailment that has affected more than 1 billion individuals across the world. Hence, knowing what to do makes all the difference. What are GLP-1 agonists in brief? These are classes of medicines that are usually...

Man Utd latest: Ederson set for full medical after Brazil exit

Man Utd latest: Ederson set for full medical after Brazil exit

Alberta expands pharmacist services and allows longer prescription refills under new agreement

Albertans with stable chronic health conditions will soon be able to receive up to 100 days of medication at a time as part of a new agreement between the Alberta government and the Alberta Pharmacists’ Association aimed at expanding access to care and reducing trips to the pharmacy.

How Online Prescription Services Are Closing the Access Gap for Patients Who Skip the Doctor’s Office

By DAMIAN WONJO Every clinician keeps a private list of the patients they don’t see. Not the ones who cancel, the ones who never book. The shift worker who reschedules the sameContinue reading...

Physiotherapy: Restoring Movement, Reducing Pain, and Improving Quality of Life

Physiotherapy is a healthcare profession dedicated to helping people regain movement, reduce pain, and improve their overall physical well-being. Whether recovering from an injury, managing a chronic condition, or improving mobility after surgery, physiotherapy plays a vital role in restoring function and enhancing quality of life.

Gluten-Free Cruise Will Set Sail in 2028 with 11 Onboard Dining Options

Celiac Cruise will take passengers on a 12-day trip and offer a worry-free experience for travelers with celiac disease

MassHealth will stop covering weight-loss drugs next week

The change will leave an estimated 22,000 MassHealth members on the hook to pay out of pocket for the pricy GLP-1s and other anti-obesity drugs. The post MassHealth will stop covering weight-loss drugs next week appeared first on Boston.com.

Adoption of generic semaglutide depends on the delivery device

The absence of standardisation in delivery devices for generic semaglutide leaves patients confused and doctors hesitant to prescribe

Doctor Who: Circuit Breaker #1 Exclusive First Look Confronts The Dalek Question We’ve Been Asking For 21 Years

If Doctor Who really has entered a new wilderness era, then stories like Doctor Who: Circuit Breaker 1 are just what the franchise needs. Relaunched in 2005, Doctor Who is now on the brink of yet another regeneration – not just a new form for the Doctor, but for the entire show. The BBC has []

I've had a UTI every few months for five years - and antibiotics don't work: Don't worry, says DR ELLIE. Here's how to beat them for good - and the hidden cause no one realises is to blame

I've had a UTI every few months for five years - and antibiotics don't work: Don't worry, says DR ELLIE. Here's how to beat them for good - and the hidden cause no one realises is to blame

Medicare patients can get GLP-1s as of July 1

Medicare beneficiaries for the first time will be eligible for coverage of breakthrough GLP-1 weight-loss medications after years of struggling to get the drugs to more seniors. Starting July 1, eligible patients can get GLP-1s to treat obesity for just 50 per month as part of a test program for Medicare, the social safety net []